Our findings showed that DBD-CAP resulted in a significant down-regulation of CD44 (the main cellular receptor for the polysaccharide hyaluronan and a prominent cancer stem cell marker) mRNA expression in all three breast cancer cell lines (Figure 10A). The gene discussed is CD44; the disease is breast carcinoma.